DIPYRIDAMOLE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dipyridamole, and when can generic versions of Dipyridamole launch?
Dipyridamole is a drug marketed by Chartwell Injectable, Dr Reddys, Eugia Pharma Speclts, Fresenius Kabi Usa, Hikma, Hospira, Ani Pharms, Barr, Chartwell Rx, Glenmark Generics, Impax Labs, Oxford Pharms, Purepac Pharm, Rising, Watson Labs, and Zydus Pharms Usa Inc. and is included in twenty-two NDAs.
The generic ingredient in DIPYRIDAMOLE is dipyridamole. There are eighteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the dipyridamole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dipyridamole
A generic version of DIPYRIDAMOLE was approved as dipyridamole by BARR on October 3rd, 1990.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DIPYRIDAMOLE?
- What are the global sales for DIPYRIDAMOLE?
- What is Average Wholesale Price for DIPYRIDAMOLE?
Summary for DIPYRIDAMOLE
| US Patents: | 0 |
| Applicants: | 16 |
| NDAs: | 22 |
| Finished Product Suppliers / Packagers: | 9 |
| Raw Ingredient (Bulk) Api Vendors: | 148 |
| Clinical Trials: | 79 |
| Patent Applications: | 3,932 |
| Drug Prices: | Drug price information for DIPYRIDAMOLE |
| What excipients (inactive ingredients) are in DIPYRIDAMOLE? | DIPYRIDAMOLE excipients list |
| DailyMed Link: | DIPYRIDAMOLE at DailyMed |
Recent Clinical Trials for DIPYRIDAMOLE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Guo-Qing Jiang | N/A |
| Clear Creek Bio, Inc. | Phase 2 |
| Rutgers, The State University of New Jersey | Phase 3 |
Pharmacology for DIPYRIDAMOLE
| Drug Class | Platelet Aggregation Inhibitor |
| Physiological Effect | Decreased Platelet Aggregation |
Medical Subject Heading (MeSH) Categories for DIPYRIDAMOLE
Anatomical Therapeutic Chemical (ATC) Classes for DIPYRIDAMOLE
US Patents and Regulatory Information for DIPYRIDAMOLE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Pharms Usa Inc | DIPYRIDAMOLE | dipyridamole | TABLET;ORAL | 040874-001 | Jan 28, 2008 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Rising | DIPYRIDAMOLE | dipyridamole | TABLET;ORAL | 040733-001 | Feb 13, 2007 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Zydus Pharms Usa Inc | DIPYRIDAMOLE | dipyridamole | TABLET;ORAL | 040874-002 | Jan 28, 2008 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Rising | DIPYRIDAMOLE | dipyridamole | TABLET;ORAL | 040733-002 | Feb 13, 2007 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Chartwell Injectable | DIPYRIDAMOLE | dipyridamole | INJECTABLE;INJECTION | 074939-001 | Apr 13, 1998 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Glenmark Generics | DIPYRIDAMOLE | dipyridamole | TABLET;ORAL | 089001-001 | Feb 5, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Oxford Pharms | DIPYRIDAMOLE | dipyridamole | TABLET;ORAL | 040542-003 | Apr 21, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
